A New Era in Schizophrenia Care: FDA Approves Weltruza, the First PDSS-Free Once-Monthly Injectable Olanzapine
By Ian Ingram, Managing Editor, MedPage Today October 9, 2026 In a significant advancement for the management of schizophrenia, the U.S. Food and Drug Administration (FDA) has officially approved Weltruza,…









